NVCR - NovoCure Limited

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201812/31/201712/31/201612/31/2015
Total Revenue248,069177,02682,88833,087
Cost of Revenue79,69855,41439,84620,574
Gross Profit168,371121,61243,04212,513
Operating Expenses
Research Development50,57438,10341,46743,748
Selling General and Administrative151,119122,642106,85672,725
Non Recurring----
Others----
Total Operating Expenses281,391216,159188,169137,047
Operating Income or Loss-33,322-39,133-105,281-103,960
Income from Continuing Operations
Total Other Income/Expenses Net-12,620-9,364-16,183-3,187
Earnings Before Interest and Taxes-33,322-39,133-105,281-103,960
Interest Expense-16,268-11,372-6,604-2,702
Income Before Tax-45,942-48,497-121,464-107,147
Income Tax Expense17,61713,16510,3814,434
Minority Interest----
Net Income From Continuing Ops-63,559-61,662-131,845-111,581
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-63,559-61,662-131,845-111,581
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-63,559-61,662-131,845-111,581